Clin2
NCT06892197Possibly a fitRecruiting

Comparing two steroids for severe pneumonia

Community Acquired Pneumonia (CAP)

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This trial compares two common steroid medicines, hydrocortisone and prednisolone, to see which works better for people with severe community-acquired pneumonia. It aims to find the best treatment to help you recover faster.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
1,600 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old.
  • You have been diagnosed with severe pneumonia that developed outside of a hospital.
  • Your doctor has decided that you need steroid treatment for your pneumonia.
  • You have not been in the hospital for more than 24 hours before starting this trial.
  • You are not pregnant or breastfeeding.
  • You do not have active tuberculosis or a serious fungal infection, and your pneumonia was not caused by the flu.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06892210Recruiting· Phase 4
Steroid comparison for COPD flare-ups

This trial compares two common steroids, hydrocortisone and prednisolone, to see which works better for treating COPD flare-ups. It may help you recover faster from a sudden worsening of your breathing.

Rønne, Bornholm
NCT07357935Not yet recruiting· Phase 1/Phase 2
Personalized steroids for severe pneumonia breathing failure

This study tests whether giving a personalized dose of steroids (anti-inflammatory medicine) early can help people with severe pneumonia-related breathing failure recover faster. It compares different steroid doses based on your body's inflammation and immune response.

NCT07152587Not yet recruiting· Phase 2/Phase 3
Anti-inflammatory treatment for severe pneumonia in the ICU

This trial tests whether adding anti-inflammatory medicine (steroids) to usual care helps people with severe pneumonia recover faster. It only includes patients who are seriously ill in the ICU, and the goal is to find the best way to reduce lung inflammation and improve outcomes.

NCT07328984Not yet recruiting· Phase 4
Comparing short versus longer steroid treatment for severe pneumonia

This study compares two different lengths of steroid treatment for people with severe Pneumocystis pneumonia (a serious lung infection). If you have improved enough by day 10 to breathe without oxygen, the study will see if stopping steroids sooner is as safe and effective as continuing them.

Montreal, Quebec
NCT07703098Not yet recruiting· Phase 4
Comparing two steroids for adrenal insufficiency after long-term steroid use

This trial compares two steroid medicines (hydrocortisone and methylprednisolone) to see which one works better for people whose adrenal glands have stopped working properly after taking high doses of steroids for a long time. It aims to find the safest and most effective way to replace the missing hormones.

Ljubljana
NCT07351500Not yet recruiting· Phase 3
Steroid treatment for severe flu pneumonia in intensive care

This study tests whether a steroid medicine can help adults in the ICU with severe flu pneumonia recover better. If you qualify, you may receive either the steroid or a placebo (dummy treatment) to see if it reduces inflammation and improves breathing.

Hear when a new Community Acquired Pneumonia (CAP) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.